ACAD
ACAD's valuation appears fair, fundamentals are somewhat mixed and weaker than expected earnings are holding it back, though estimates vary widely.
ACAD vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 13x | 24x | 47% lower-47% |
| PE percentile | 28 | 50 | 45% lower-45% |
| EPS | $2.22 | -$0.32 | $2.54 higher+$2.54 |
| FCF | $174.4M | -$4.9M | +$179.3M+$179.3M |
| Loading historical comparisons… | |||
ACAD’s earnings are above their historical averages, while its earnings multiple is lower.
ACAD Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly deteriorating |
| Forward earnings | Strong decline |
| Forward revenue | Strong growth |
| Forward profitability | Expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Wide |
ACAD’s outlook is mixed, with weaker expected earnings weighing on the picture.
ACAD PE Valuation
This table applies ACAD's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
ACAD Earnings Per Share
This chart tracks ACAD's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
ACAD Quarterly Revenue
This chart tracks ACAD's quarterly revenue over time and shows how sales are changing from year to year.
ACAD Free Cash Flow
This chart tracks ACAD's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
ACAD Total Shares
This chart tracks changes in ACAD's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
ACAD Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
ACAD PE vs Healthcare Sector
This chart compares ACAD's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
ACAD Weekly Price
This chart uses ACAD's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
ACAD Weekly Moving Averages
This chart compares ACAD's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
ACAD Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
HIMS
HIMS's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to a return to profit and improving margins, though analyst coverage is limited and estimates vary widely.
HIMS vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 50x | 81x | 39% lower-39% |
| PE percentile | 21 | 50 | 58% lower-58% |
| EPS | -$0.63 | -$0.12 | $0.50 lower-$0.50 |
| FCF | $89.9M | $42.3M | 112% higher+112% |
| Loading historical comparisons… | |||
HIMS’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Turning positive |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
HIMS’s outlook is generally improving, supported by an expected return to profitability.
HIMS PE Valuation
This table applies HIMS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
HIMS Earnings Per Share
This chart tracks HIMS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
HIMS Quarterly Revenue
This chart tracks HIMS's quarterly revenue over time and shows how sales are changing from year to year.
HIMS Free Cash Flow
This chart tracks HIMS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
HIMS Total Shares
This chart tracks changes in HIMS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
HIMS Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
HIMS PE vs Healthcare Sector
This chart compares HIMS's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
HIMS Weekly Price
This chart uses HIMS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
HIMS Weekly Moving Averages
This chart compares HIMS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
HIMS Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.